Lv1
10 积分 2025-02-06 加入
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual
1个月前
已完结
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
1个月前
已完结
GD2-targeting CAR T cells in high-risk neuroblastoma: a phase 1/2 trial
5个月前
已完结
Clinical Pharmacology Profile of AMG 119, the First Chimeric Antigen Receptor T (CAR‐T) Cell Therapy Targeting Delta‐Like Ligand 3 (DLL3), in Patients with Relapsed/Refractory Small Cell Lung Cancer (SCLC)
5个月前
已完结
In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus
6个月前
已完结
皖公网安备34019202002308
